CS MEDICA signs agreements with two out of the three leading Danish pharmacy chains.
CS MEDICA A/S’s (”CS MEDICA” or the ”Company”) long-awaited breakthrough in the Danish pharmacy world is now a reality, as they close agreements with two out of the three leading pharmacy chains in Denmark. With this agreement the Company get access to 400 pharmacies in Denmark, with shelf space as well as online availability for the full CANNASEN® CBD product line.
Lone Henriksen, CEO CS MEDICA A/S comments
“We are proud to announce, that we finally made it to the pharmacies, with agreements signed with two of the three leading pharmacy chains in Denmark. We will use and optimize this new position in the market by accelerating our listings and built brand stores on the growing players within the online pharmacy channel.”
CS MEDICA today finalized the cooperation agreement, in voluntary assortment, with two out of the three leading pharmacy chains in Denmark, Pharmaplus and Apotekeren.
Pharmaplus with its 27 main pharmacies and 89 subsidiary pharmacies have agreed to list the full CANNASEN® CBD product line both instore and on their web shop.
Apotekeren with its 102 main pharmacies and 182 subsidiary pharmacies, have agreed to start with the following 4 CANNASEN® CBD products instore and the full product line on their web shop.
CANNASEN® CBD Psoriasis Gel
CANNASEN® CBD Psoriasis Lotion
CANNASEN® CBD Arthritis Gel
CANNASEN® CBD Anti hair loss Serum
The Danish pharmacists have been a milestone in CS MEDICA’s go-to-market strategy, with their innovative CBD products supported with clinical trials, now launching into the Danish market.
To support the training of the pharmacies in medical device products with CBD, CS MEDICA has engaged a sales consultant with more than 20 years of experience within the pharmacy industry.
For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@cs-medica.com
Website: https://www.cs-medica.com/
CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.
The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.
